Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.